Filing Details
- Accession Number:
- 0001209191-18-063954
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-21 17:07:56
- Reporting Period:
- 2018-12-20
- Accepted Time:
- 2018-12-21 17:07:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1685071 | Dova Pharmaceuticals Inc. | DOVA | Pharmaceutical Preparations (2834) | 813858961 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1709418 | Sean Stalfort | 200 Garrett Street, Suite S Charlottesville VA 22902 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-20 | 31,000 | $6.26 | 635,665 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.02to $6.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range setforth in footnote (1) to this Form 4.
Billionaire Hedge Funds
